Kinetics of gold nanoparticles in the human placenta.

We studied the transfer of PEGylated gold nanoparticles through perfused human placenta. In 'once-through' perfusions using 15 and 30nm nanoparticles both maternal and fetal outflows were collected. Recirculating perfusions using 10 or 15nm nanoparticles lasted 6h. The gold concentration in samples was analysed on ICP-MS. The reference compound antipyrine crossed the placenta rapidly, as expected. In open perfusions nanoparticles were detected in maternal but not in fetal outflow, suggesting the lack of placental transfer. During 6h re-circulating perfusions, no particles were detected in fetal circulation. Using transmission electron microscopy (TEM) and silver enhancement, nanoparticles could be visualized in the placental tissue mainly in the trophoblastic cell layer. In in vitro experiments, nanoparticles were taken up by BeWo choriocarcinoma cells and retained inside the cells for an extended period of 48h. In conclusion, PEGylated gold nanoparticles of the size 10-30nm did not cross the perfused human placenta in detectable amounts into the fetal circulation within 6h. Whether PEGylated gold nanoparticles eventually are able to cross placenta and whether nanoparticles affect placental functions needs to be further studied.

[1]  P. Myllynen,et al.  Transplacental passage of lamotrigine in a human placental perfusion system in vitro and in maternal and cord blood in vivo , 2003, European Journal of Clinical Pharmacology.

[2]  L. Leach,et al.  Structure and permeability of human placental microvasculature , 1997, Microscopy research and technique.

[3]  S. Moestrup,et al.  Megalin-mediated endocytosis of transcobalamin-vitamin-B12 complexes suggests a role of the receptor in vitamin-B12 homeostasis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Kirsi Vähäkangas,et al.  Ex vivo perfusion of the human placental cotyledon: implications for anesthetic pharmacology , 2000 .

[5]  R. Sager,et al.  Transport of immunoglobulin G and its subclasses across the in vitro-perfused human placenta. , 1995, American journal of obstetrics and gynecology.

[6]  Karluss Thomas,et al.  Research strategies for safety evaluation of nanomaterials, Part I: evaluating the human health implications of exposure to nanoscale materials. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[7]  Mansoor Amiji,et al.  Cellular interactions and in vitro DNA transfection studies with poly(ethylene glycol)-modified gelatin nanoparticles. , 2005, Journal of pharmaceutical sciences.

[8]  A. Huch,et al.  Dual in vitro perfusion of an isolated lobe of human placenta: method and instrumentation. , 1985, Contributions to gynecology and obstetrics.

[9]  O Pelkonen,et al.  Carbamazepine and Its Metabolites in Human Perfused Placenta and in Maternal and Cord Blood , 1995, Epilepsia.

[10]  M. Panigel.  Placental perfusion experiments , 1962 .

[11]  Russell J Mumper,et al.  Comparison of cell uptake, biodistribution and tumor retention of folate-coated and PEG-coated gadolinium nanoparticles in tumor-bearing mice. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[12]  M F Hoylaerts,et al.  Passage of intratracheally instilled ultrafine particles from the lung into the systemic circulation in hamster. , 2001, American journal of respiratory and critical care medicine.

[13]  Min Chen,et al.  Formation of nucleoplasmic protein aggregates impairs nuclear function in response to SiO2 nanoparticles. , 2005, Experimental cell research.

[14]  David E Newby,et al.  Do inhaled carbon nanoparticles translocate directly into the circulation in humans? , 2006, American journal of respiratory and critical care medicine.

[15]  Wen-Tso Liu,et al.  Nanoparticles and their biological and environmental applications. , 2006, Journal of bioscience and bioengineering.

[16]  Kirsi Vähäkangas,et al.  Gene transfer to human placenta ex vivo: a novel application of dual perfusion of human placental cotyledon. , 2002, American journal of obstetrics and gynecology.

[17]  M. Benedetti,et al.  Toxicological impact studies based on Escherichia coli bacteria in ultrafine ZnO nanoparticles colloidal medium. , 2006, Nano letters.

[18]  H. Schneider.  Placental transport function. , 1991, Reproduction, fertility, and development.

[19]  P. Kaufmann,et al.  Pressure dependence of so‐called transtrophoblastic channels during fetal perfusion of human placental villi , 1997, Microscopy research and technique.

[20]  K. Donaldson,et al.  Serum exposed to nanoparticle carbon black displays increased potential to induce macrophage migration. , 2005, Toxicology letters.

[21]  T. Niidome,et al.  Stabilizing of plasmid DNA in vivo by PEG-modified cationic gold nanoparticles and the gene expression assisted with electrical pulses. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[22]  K. Donaldson,et al.  Increased inflammation and altered macrophage chemotactic responses caused by two ultrafine particle types , 2004, Occupational and Environmental Medicine.

[23]  G. Desoye,et al.  Location of insulin receptors in the placenta and its progenitor tissues , 1997, Microscopy research and technique.

[24]  Hongzhe Sun,et al.  Transferrin-mediated gold nanoparticle cellular uptake. , 2005, Bioconjugate chemistry.

[25]  L. Leach.  The phenotype of the human materno‐fetal endothelial barrier: molecular occupancy of paracellular junctions dictate permeability and angiogenic plasticity* , 2002, Journal of anatomy.